May 8th 2024, 3:00pm
The Food and Drug Administration granted a Biologics License Application for subcutaneous Opdivo for potential approval.
May 6th 2024, 7:00pm
Treatment with a certain radiation therapy worsens quality of life in patients with prostate cancer. An expert explains ways to mitigate side effects.
May 2nd 2024, 5:00pm
After recovering from testicular cancer, I feel as though I've earned a second life where I face my fears head-on.
April 30th 2024, 7:00pm
A urine test was shown to decrease the need for invasive cystoscopies in patients with non-muscle-invasive bladder cancer.
April 24th 2024, 1:00pm
Treatment with Enhertu “is an unprecedented approval” for patients with HER2-positive solid tumors who did not have many options, an expert told CURE®.
April 22nd 2024, 11:48pm
A treatment combination of Anktiva and Bacillus Calmette-Guérin was approved by the FDA for certain patients with non-muscle-invasive bladder cancer.
April 19th 2024, 9:00pm
The survival benefit observed with Padcev plus Keytruda was “unlike anything we’d seen before” for advanced bladder cancer, according to an expert.
April 19th 2024, 3:00pm
From the Allman Brothers Band’s singer Dickey Betts dying after a cancer diagnosis to the “Shopaholic” author announcing her glioblastoma diagnosis, here’s what is happening in the cancer space this week.
April 18th 2024, 7:00pm
Topline data has been released from a trial of antibody-drug conjugate FG-3246 for patients with pretreated, metastatic castration-resistant prostate cancer.
April 18th 2024, 3:00pm
For decades, researchers have been seeking a therapy to improve outcomes for patients with clear cell renal cell carcinoma who underwent a nephrectomy.
When a Thoughtless Mammogram Reminder Reopened a Deep Cancer Wound
A Lifelong Advocate and Innovator
Personalized Breast Cancer Care for Older Adults Goes Beyond Age
Unmatched Energy, Every Single Day
